Wird geladen...
Novel amodiaquine derivatives potently inhibit Ebola virus infection
Ebola virus disease is a severe disease caused by highly pathogenic Ebolaviruses. Although it shows a high mortality rate in humans, currently there is no licensed therapeutic. During the recent epidemic in West Africa, it was demonstrated that administration of antimalarial medication containing am...
Gespeichert in:
| Veröffentlicht in: | Antiviral Res |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier B.V.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6374029/ https://ncbi.nlm.nih.gov/pubmed/30395872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.10.025 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|